TGF superfamily and MMP2, MMP9, TIMP1 genes expression in the endometrium of women with impaired reproduction

Folia Histochemica et Cytobiologica

Volumn 45, Issue SUPPL. 1, 2007, Pages 143-148

  Skrzypczak, Jana ^a   Wirstlein, Przemysław ^a   Mikołajczyk, Mateusz ^a   Ludwikowski, Grzegorz ^b   Zak, Tomasz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Endometrium; Imaired reproduction; MMP2; MMP9; TGF 2; TIMP1

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR; MESSENGER RNA; MMP2 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FEMALE INFERTILITY; GENE EXPRESSION; HUMAN; HYSTEROSCOPY; IDIOPATHIC DISEASE; OVULATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUS ABORTION; ARTICLE; BIOSYNTHESIS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PREDICTION AND FORECASTING; RECURRENT ABORTION; REPRODUCIBILITY;

ABORTION, HABITUAL; ADULT; BASE SEQUENCE; ENDOMETRIUM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFERTILITY, FEMALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 44949221115     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Tabibzadeh S, Babaknia A. The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue destruction. Mol Hum Reprod. 1995;10:1579-1602.
2. Dimitriadis E, White CA, Jones RL, Salamonsen LA. Cytokines, chemokines and growth factiors in endometrium related to implantation. Hum Reprod. 2005;11:613-630.
3. Makrigiannis A, Minas V, Kalantavidon SN, Nikas G, Chrousos G. Hormonal and cytokine regulation of early implantation. TRENDS in Endocrynol Metabol. 2006;17:178-185.
4. Piek E, Heldin CH, Ten Dijke P. Specificity, diversity and regulation in TGF superfamily signalling. FASEB. 1999;13:2105-2124.
5. Sinha S, Nevett C, Shuttleworth CA, Kielty CM. Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins. Matrix Biol. 1998;17:529-545.
6. Gold LI, Saxena BN, Mittal KR et al.. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometruim: evidence for paracrine and autocrine action. Cancer Res. 1994;54:2347-2358.
7. Godkin JD, Dore JJ. Transforming growth factor beta and the endometrium. Rev Reprod. 1998;3:1-6.
8. Chung IB, Yelian FD, Zaher FM et al.. Expression and regulation of vascular endothelial growth factor in first trimester trophoblast cell line. Placenta. 2000;21:320-324.
9. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II and IGEBP-1. Exp Cell Res. 1995;217:419-427.
10. Perrier d'Hauterive S, Charlet-Renard C, Dubois M et al.. Human endometrial leukemia inhibitory factor and interleukin-6: control of secretion by transforming growth factor beta-related members. Neuroimmunomodulation. 2005;12:157-163.
11. Letterio JJ, Roberts AB. TGF : a critical modulator of immune cell function. Clin. Immunol Immunopathol. 1997;84:244-250.
12. Tang M, Taylor HS, Tabibzadeh S. In vivo gene transfer of lefty leads to implantation failure in mice. Hum Reprod. 2005;20:1772-1778.
13. Inagaki N, Stern C, McBain J, Lopata A, Kornman L, Wilkinson D. Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer. Hum Reprod. 2003;18:608-615.
14. Jokimaa V, Oksjoki S, Kujari H, Vuorio E, Antilla L. Altered expression of genes involved in the production and degradation of endometrial extracellular patients with unexplained infertility and recurrent miscarriage. Mol Hum Reprod. 2002;8:1111-1116.
15. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett. 2004:26:509-515.
16. Li TC, Dockery P, Cooke ID. Endometrial development in the luteal phase of woman with various types of infertility: comparison with women of normal fertility. Hum Reprod. 1991;6:325-330.
17. Serle E, Aplin JD, Li TC et al.. Endometrial differentiation in the peri-implantation phase of women with recurrent miscarriage: a morphological and immunohistochemical study. Fertil Steril. 1994;62:989-996.
18. Tabibzadeh S. Molecular control of the implantation window. Hum Reprod Update. 1998;4:465-471.
19. Jones R, Stoikos Ch, Findlay J, Salamonsen A. TGF-β superfamily expression and actions in the endometria and placenta. Reproduction. 2006;132:217-232.
20. Herrler A, von Rango U, Beier HM. Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish. Reprod Biomed Online. 2003;6:244-256.
21. Sachdevaa G, Patila V, Katkama RR, Manjramkara DD, Kholkutea SD, Puri CP. Expression profiles of endometrial leukemia inhibitory factor, transforming growth factor beta2 (TGFbeta2), and TGFbeta2 receptor in infertile bonnet monkeys. Biol Reprod. 2001;65:1-8.
22. Kothapalli R, Buyuksal I, Wu SQ, Chegini N, Tabibzadeh S. Detection of ebaf, a novel human gene of the TGF superfamily: association of gene expression with endometrial bleeding. J Clin Invest. 1997;99:2342-2350.
23. Tabibzadeh S, Manson JM, Shea W, Cai Y, Murray MJ, Lessy B. Dysregulated expression of ebaf, a novel molecular defect in the endometria patients with infertility. J Clin Endocrinol Metab. 2000;85:2526-2536.
24. Baird DD, Weinderg CR, Wilox AJ, McConnaughey DR, Musey PI, Colins DC. Hormonal profiles of natural conception cycles ending in early, unrecognised pregnancy loss. J Clin Endocrinol Metab. 1991;72:793-800.
25. Wu RJ, Zhon FI. Expression of matrix metalloproteinases-9 and tissue inhibitor of metallloproteinases-1 mRNA in the endometrium during mid-luted phase in women with unexplained infertility. Zhonghua Fu Chan Ke Za Zhi. 2003;6:346-349.
26. Bany BM, Harvey MB, Schultz GA. Expression of matrix metalloproteinases-2 and -9 in the mouse uterus during implantation and oil-induced decidualization. J Reprod Fertil. 2000;120:125-134.
27. Skrzypczak J, Wirstlein P, Mikolajczyk M. Could the defects in the endometrial extracellular matrix during the implantation be a cause for impaired fertile? Am J Reprod Immunol. 2007;57:40-48.